HomeWorldWHO grants emergency use listing to Bharat Biotech's Covaxin

WHO grants emergency use listing to Bharat Biotech’s Covaxin

@the_news_21

In a major development, the WHO on Wednesday said it has granted emergency use listing (EUL) to Bharat Biotech’s COVID-19 vaccine Covaxin.

This comes after the Technical Advisory Group (TAG), an independent advisory committee of WHO recommended EUL status for Covaxin.

“WHO has granted emergency use listing (EUL) to #COVAXIN (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19,” the global health body said in a tweet.

Dr Poonam Khetarpal Singh, Regional Director of WHO South East Asia, in a tweet, said, “Congratulations India for Emergency Use Listing of its indigenously produced COVID-19 vaccine Covaxin.”

“The Technical Advisory Group of WHO has recommended Emergency Use Listing status for Covaxin,” a source told PTI before the WHO announcement.

The TAG on October 26 had sought “additional clarifications” from the company for Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine.

Prime Minister Narendra Modi met WHO Director General Dr Tedros Adhanom Ghebreyesus at the G20 summit recently.

The TAG-EUL is an independent advisory group that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.

Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

In June, the company said it concluded the final analysis of Covaxin efficacy from Phase 3 trials.

Bharat Biotech’s Covaxin and AstraZeneca and Oxford University’s Covishield are the two widely used vaccines in India.

Subscribe to TheNews21

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

44 COMMENTS

  1. You can protect yourself and your ancestors close being cautious when buying prescription online. Some druggist’s websites function legally and offer convenience, reclusion, cost savings and safeguards for purchasing medicines. http://playbigbassrm.com/

  2. Join the millions friendly strapping on fanduel casino Virginia – the #1 real money casino app in America.
    Pick up your $1000 PLAY IT AGAIN gratuity and turn every twirl, hand and somersault into legitimate readies rewards.
    Firm payouts, whopping jackpots, and habitual effect – download FanDuel Casino again and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

@the_news_21

In a major development, the WHO on Wednesday said it has granted emergency use listing (EUL) to Bharat Biotech’s COVID-19 vaccine Covaxin.

This comes after the Technical Advisory Group (TAG), an independent advisory committee of WHO recommended EUL status for Covaxin.

“WHO has granted emergency use listing (EUL) to #COVAXIN (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19,” the global health body said in a tweet.

Dr Poonam Khetarpal Singh, Regional Director of WHO South East Asia, in a tweet, said, “Congratulations India for Emergency Use Listing of its indigenously produced COVID-19 vaccine Covaxin.”

“The Technical Advisory Group of WHO has recommended Emergency Use Listing status for Covaxin,” a source told PTI before the WHO announcement.

The TAG on October 26 had sought “additional clarifications” from the company for Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine.

Prime Minister Narendra Modi met WHO Director General Dr Tedros Adhanom Ghebreyesus at the G20 summit recently.

The TAG-EUL is an independent advisory group that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.

Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

In June, the company said it concluded the final analysis of Covaxin efficacy from Phase 3 trials.

Bharat Biotech’s Covaxin and AstraZeneca and Oxford University’s Covishield are the two widely used vaccines in India.

Html code here! Replace this with any non empty text and that's it.

44 COMMENTS

  1. You can protect yourself and your ancestors close being cautious when buying prescription online. Some druggist’s websites function legally and offer convenience, reclusion, cost savings and safeguards for purchasing medicines. http://playbigbassrm.com/

  2. Join the millions friendly strapping on fanduel casino Virginia – the #1 real money casino app in America.
    Pick up your $1000 PLAY IT AGAIN gratuity and turn every twirl, hand and somersault into legitimate readies rewards.
    Firm payouts, whopping jackpots, and habitual effect – download FanDuel Casino again and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img